Daily news
Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.
An adverse effect of an injectable cosmetic procedure: a case of mistaken identities. feedly.com/e/6GK7IPkE #cosmeticdermatology
Treatment of forehead/glabellar complex with BoNT-A + HA vs BoNT-A alone split-face rater-blinded RCT. feedly.com/e/TPIpsGru #dermalfiller
Midface and Perioral Volume Restoration: A Conversation Between the US and Italy. feedly.com/e/u6BmnpvB #cosmeticdermatology
Percutaneous collagen induction: post-acne scarring effective & safe treatment in different phototypes ncbi.nlm.nih.gov/pubmed/23216209 #dermatology
Confirmed efficacy of topical nifedipine in the treatment of facial wrinkles ncbi.nlm.nih.gov/pubmed/23688162 #skinaging #rhytides
Clinical analysis and classification of dark eye circle ncbi.nlm.nih.gov/pubmed/23879616
AEs associated with botulinum toxin injection: study of 5310 treatments in 1819 patients ncbi.nlm.nih.gov/pubmed/23537074 #cosmeticdermatology
IPO News: Botox biotech Revance Therapeutics sets terms for $75 million IPO (by Renaissance Capital) zite.to/1f8VuXl
JAMA papers raise questions about FDA drug and device approval zite.to/KXsabT
Rate of non-melanoma skin cancer predicted to increase by over 350% #skincancer #NMskincancer zite.to/1gnuWoP